勘误：拉丁美洲七个国家慢性阻塞性肺疾病患者使用的呼吸药物：LASSYC研究[勘误]
Erratum: Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study [Corrigendum].
出版信息
Int J Chron Obstruct Pulmon Dis. 2019 Jan 18;14:241. doi: 10.2147/COPD.S194429. eCollection 2019.
Abstract
[This corrects the article on p. 1545 in vol. 13, PMID: 29785104.].
摘要
[本文纠正了第13卷第1545页的文章， PMID: 29785104。]
相似文献
1
Erratum: Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study [Corrigendum].勘误：拉丁美洲七个国家慢性阻塞性肺疾病患者使用的呼吸药物：LASSYC研究[勘误]
Int J Chron Obstruct Pulmon Dis. 2019 Jan 18;14:241. doi: 10.2147/COPD.S194429. eCollection 2019.
2
Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.来自七个拉丁美洲国家的慢性阻塞性肺疾病（COPD）患者使用的呼吸药物：LASSYC研究
Int J Chron Obstruct Pulmon Dis. 2018 May 11;13:1545-1556. doi: 10.2147/COPD.S154097. eCollection 2018.
3
Erratum: Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum].勘误：慢性阻塞性肺疾病患者的支气管扩张：不仅仅是一种合并症？[勘误]
Int J Chron Obstruct Pulmon Dis. 2019 Jan 18;14:245. doi: 10.2147/COPD.S194432. eCollection 2019.
4
Erratum: Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study [Corrigendum].勘误：噻托溴铵/奥达特罗与噻托溴铵治疗日本慢性阻塞性肺疾病患者的疗效比较：DYNAGITO研究结果[勘误]
Int J Chron Obstruct Pulmon Dis. 2018 Oct 30;13:3587. doi: 10.2147/COPD.S191099. eCollection 2018.
5
Erratum: Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum].勘误：茚达特罗/格隆溴铵在日本慢性阻塞性肺疾病患者中的疗效和安全性：SHINE研究的亚组分析[勘误]
Int J Chron Obstruct Pulmon Dis. 2017 Jan 10;12:231. doi: 10.2147/COPD.S127610. eCollection 2017.
6
Erratum: Russian guidelines for the management of COPD: algorithm of pharmacologic treatment [Corrigendum].勘误：俄罗斯慢性阻塞性肺疾病管理指南：药物治疗算法[勘误]
Int J Chron Obstruct Pulmon Dis. 2019 Jan 18;14:243. doi: 10.2147/COPD.S194430. eCollection 2019.
7
Erratum: Predicting frequent COPD exacerbations using primary care data [Corrigendum].勘误：使用初级保健数据预测慢性阻塞性肺疾病频繁急性加重 [勘误说明]
Int J Chron Obstruct Pulmon Dis. 2018 Aug 15;13:2471. doi: 10.2147/COPD.S181390. eCollection 2018.
8
Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study.来自七个拉丁美洲国家的慢性阻塞性肺疾病患者对吸入疗法的依从性：拉丁美洲慢性阻塞性肺疾病吸入治疗研究（LASSYC研究）
PLoS One. 2017 Nov 15;12(11):e0186777. doi: 10.1371/journal.pone.0186777. eCollection 2017.
9
Erratum: Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey [Corrigendum].勘误：《持续应对慢性阻塞性肺疾病国际患者调查》参与者的健康行为及其相关因素[勘误]
Int J Chron Obstruct Pulmon Dis. 2017 Mar 15;12:859. doi: 10.2147/COPD.S133394. eCollection 2017.
10
Erratum: The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia [Corrigendum].勘误：炎症标志物在预测伴有或不伴有嗜酸性粒细胞增多的慢性阻塞性肺疾病（COPD）病例再入院和死亡率方面的效用[勘误说明]
Int J Chron Obstruct Pulmon Dis. 2016 Mar 1;11:417. doi: 10.2147/COPD.S103721. eCollection 2016.
Zotero 插件